These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6582585)

  • 41. D+ platelet transfusions in D- patients: cause for concern?
    Bartley AN; Carpenter JB; Berg MP
    Immunohematology; 2009; 25(1):5-8. PubMed ID: 19856725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Approaches to preventing or reversing platelet alloimmunization using animal models.
    Slichter SJ; Weiden PL; Kane PJ; Storb RF
    Transfusion; 1988; 28(2):103-8. PubMed ID: 3354038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusions.
    Stohlawetz P; Stiegler G; Knöbl P; Höcker P; Panzer S
    Ann Hematol; 1999 Jun; 78(6):271-3. PubMed ID: 10422629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alloimmunization following platelet transfusion: the absence of a dose-response relationship.
    Dutcher JP; Schiffer CA; Aisner J; Wiernik PH
    Blood; 1981 Mar; 57(3):395-8. PubMed ID: 7459428
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low-dose prophylactic platelet transfusions in recipients of an autologous peripheral blood progenitor cell transplant and patients with acute leukemia: a randomized controlled trial with a sequential Bayesian design.
    Tinmouth A; Tannock IF; Crump M; Tomlinson G; Brandwein J; Minden M; Sutton D
    Transfusion; 2004 Dec; 44(12):1711-9. PubMed ID: 15584985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Limited value of in vitro techniques for the detection of leukocyte alloantibodies during granulocyte transfusion therapy.
    Wiesneth M; Pflieger H; Goldmann SF; Arnold R
    Vox Sang; 1981; 40(6):416-21. PubMed ID: 7027623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet transfusions.
    Stroncek DF; Rebulla P
    Lancet; 2007 Aug; 370(9585):427-38. PubMed ID: 17679020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A prospective randomized trial of HLA-matched versus mismatched single-donor platelet transfusions in cancer patients.
    Messerschmidt GL; Makuch R; Appelbaum F; Ungerleider RS; Abrams R; O'Donnell J; Holohan TV; Fontana J; Wright D; Anagnou NP
    Cancer; 1988 Aug; 62(4):795-801. PubMed ID: 3293762
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Consequences of prior alloimmunization during granulocyte transfusion.
    Appelbaum FR; Trapani RJ; Graw RG
    Transfusion; 1977; 17(5):460-4. PubMed ID: 910262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effects of splenectomy on engraftment and platelet transfusion requirements in patients with chronic myelogenous leukemia undergoing marrow transplantation.
    Banaji M; Bearman SI; Buckner CD; Clift RA; Bensinger WI; Petersen FB; Slichter SJ; McGuffin RW; Sanders JE; Stewart PS
    Am J Hematol; 1986 Jul; 22(3):275-83. PubMed ID: 3521264
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lack of predictive value of antileukocyte antibody screening in granulocyte transfusion therapy.
    Ungerleider RS; Appelbaum FR; Trapani RJ; Deisseroth AB
    Transfusion; 1979; 19(1):90-4. PubMed ID: 432918
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hematological support in patients undergoing allogenetic bone marrow transplantation.
    Osterwalder B; Gratwohl A; Reusser P; Tichelli A; Speck B
    Recent Results Cancer Res; 1988; 108():44-52. PubMed ID: 3051211
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Canine platelet alloimmunization: the role of donor selection.
    Slichter SJ; O'Donnell MR; Weiden PL; Storb R; Schroeder ML
    Br J Haematol; 1986 Aug; 63(4):713-27. PubMed ID: 3730294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prophylactic granulocyte transfusions: results of a randomized controlled trial in patients with acute myelogenous leukemia.
    Ford JM; Cullen MH; Roberts MM; Brown LM; Oliver RT; Lister TA
    Transfusion; 1982; 22(4):311-6. PubMed ID: 7048657
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alloimmunization against platelets, granulocytes and erythrocytes in multi-transfused patients in Iranian population.
    Younesi MR; Louni Aligoudarzi S; Bigdeli R; Lashgari M; Mazaheri H; Asgary V
    Transfus Apher Sci; 2016 Oct; 55(2):205-211. PubMed ID: 27318433
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the effects of different transfusion trigger levels during the treatment of childhood acute lymphoblastic leukemia.
    Paananen P; Arola MO; Pelliniemi TT; Salmi TT; Lähteenmäki PM
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):745-9. PubMed ID: 19734805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alloimmunization following prophylactic granulocyte transfusion.
    Schiffer CA; Aisner J; Daly PA; Schimpff SC; Wiernik PH
    Blood; 1979 Oct; 54(4):766-74. PubMed ID: 476300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Recent developments in the supportive therapy of acute myelogenous leukemia.
    Levine AS; Deisseroth AB
    Cancer; 1978 Aug; 42(2 Suppl):883-94. PubMed ID: 28827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of universal vs bedside leukoreductions on the alloimmunization to platelets and the platelet transfusion refractoriness.
    Mishima Y; Tsuno NH; Matsuhashi M; Yoshizato T; Sato T; Ikeda T; Watanabe-Okochi N; Nagura Y; Sone S; Kurokawa M; Okazaki H
    Transfus Apher Sci; 2015 Feb; 52(1):112-21. PubMed ID: 25467707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.